Dermatology · New York, NY
NPI
1023015245
Since 2005
Specialty
Dermatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
200 W 58th St
New York, NY, 10019
Phone (212) 757-7010
Groups this clinician bills Medicare through
Medicare paid, 2024
$246K
5,888 services
Medicare patients, 2024
424
Average age 75
Drug cost, 2024
$4.1M
16,000 prescriptions
Company payments, 2025
$87.88
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pinkas E Lebovits was code 17003 (destruction skin lesion), 2,924 times for 152 patients. In total Pinkas E Lebovits billed 5,888 services in 40 codes, and Medicare paid $246K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,924 | 152 | $6.21 | $18K |
| 99213 Office E&M - Established | Office | 911 | 314 | $81.23 | $74K |
| 17000 Destruction Skin Lesion | Office | 470 | 165 | $42.90 | $20K |
| 11102 Skin Biopsy | Office | 337 | 164 | $75.34 | $25K |
| 17110 Destruction Skin Lesion | Office | 270 | 146 | $102.97 | $28K |
| 11103 Skin Biopsy | Office | 163 | 89 | $47.05 | $7,669 |
| 17111 Destruction Skin Lesion | Office | 142 | 67 | $121.50 | $17K |
| 99203 Office E&M - New | Office | 129 | 129 | $96.96 | $13K |
| 99214 Office E&M - Established | Office | 109 | 58 | $115.54 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 86 | 27 | $0.75 | $64.89 |
| 11901 Skin | Office | 76 | 19 | $57.69 | $4,385 |
| 99212 Office E&M - Established | Office | 66 | 50 | $49.64 | $3,277 |
| 17004 Destruction Skin Lesion | Office | 45 | 25 | $157.06 | $7,068 |
| 10060 Skin | Office | 22 | 19 | $111.28 | $2,448 |
| 99202 Office E&M - New | Office | 19 | 19 | $59.86 | $1,137 |
By year: 2022 $237K for 5,082 services; 2023 $216K for 4,990 services; 2024 $246K for 5,888 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pinkas E Lebovits prescribed most often to Medicare patients was Ketoconazole, with 2,595 prescriptions and refills. In total Pinkas E Lebovits wrote 16,000 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 2,595 | 2,630 | 706 | $39K |
| Ammonium Lactate Generic | 2,150 | 2,216 | 830 | $35K |
| Triamcinolone Acetonide Generic | 1,259 | 1,317 | 704 | $13K |
| Fluocinonide Generic | 981 | 981 | 157 | $89K |
| Mometasone Furoate Generic | 920 | 941 | 346 | $22K |
| Tretinoin Generic | 781 | 916 | 265 | $69K |
| Clobetasol Propionate Generic | 725 | 737 | 237 | $65K |
| Metronidazole Generic | 603 | 613 | 217 | $25K |
| Hydrocortisone Generic | 599 | 607 | 374 | $6,565 |
| Tacrolimus Generic | 500 | 509 | 204 | $132K |
| Clindamycin Phosphate Generic | 465 | 481 | 169 | $17K |
| Clotrimazole Generic | 371 | 376 | 162 | $8,111 |
| Nystatin Generic | 341 | 348 | 118 | $5,102 |
| Mupirocin Generic | 325 | 325 | 227 | $2,073 |
| Opzelura Ruxolitinib Phosphate | 315 | 316 | 80 | $625K |
Brand drugs: 1,863 claims; generic drugs: 14,137 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pinkas E Lebovits $87.88 ($87.88 in general payments such as food, travel and fees) from 4 companies. The largest payer was Botanix SB Inc with $42.09.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.